As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum

After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.

Scroll to Top